Skip to content
OpenCapital
Get started

Protara Therapeutics, Inc. TARA Q4 2025 Annual earnings

Reported March 10, 2026 · Before market open

EPS-$0.37Miss by $0.05
EPS estimate-$0.32

Next report

Aug 10, 2026 (In 1 week)
EPS estimate-$0.33

Versus estimates

Diluted EPS

Q1 2026-$0.31Beat by $0.05
Q4 2025-$0.37Miss by $0.05
Q3 2025-$0.31Beat by $0.08Q2 2025-$0.35Beat by $0.08Q1 2025-$0.29Beat by $0.18Q4 2024-$0.48Beat by $0.09

Ask the moment Protara Therapeutics, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Protara Therapeutics, Inc. report Q4 2025 earnings?
Protara Therapeutics, Inc. (TARA) reported Q4 2025 earnings on March 10, 2026 before market open.
What were Protara Therapeutics, Inc.'s Q4 2025 revenue and EPS?
Protara Therapeutics, Inc. reported eps of $-0.37 for Q4 2025.
Did Protara Therapeutics, Inc. beat estimates in Q4 2025?
EPS missed the consensus estimate of $-0.32 by $0.05.
How did Protara Therapeutics, Inc.'s Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 22.9% from $-0.48.
Where can I find Protara Therapeutics, Inc.'s Q4 2025 SEC filings?
You can read the 8-K earnings release (0001213900-26-025432) and the 10-K periodic report (0001213900-26-025433) directly on SEC EDGAR. The filing index links above go to sec.gov.